[Webinar] Exclusively Life Sciences Series - CREATES Act: What we've learned so far and recommendations for the industry

September 29th, 12:00 pm - 1:00 pm EST
Allen & Overy LLP

Allen & Overy LLP

September 29th, 2022
12:00 PM - 1:00 PM EST

In late 2019, Congress enacted the “CREATES Act”, which established a private right of action in which generic or biosimilar manufacturers may sue an innovator for an injunction and monetary award for not selling samples of an innovator product needed for purposes of developing a generic or biosimilar version. This program will explore the fundamentals of this Act in detail, recent litigation and provide recommendations for innovators to follow when a CREATES request is made.


J Bennett

John Bennett
Partner, Boston

K Kieckhafer

Katherine Kieckhafer
Associate, Boston


Shaobo Zhu
Associate, Boston

CLE accreditation pending.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Allen & Overy LLP | Attorney Advertising


Allen & Overy LLP

Allen & Overy LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.